- On August 25, Hong Kong stock indices opened higher and then trended lower, with the Hang Seng Index falling 0. 24 % to 25456 points.
- Sector performance showed strong gains in biomedicine, optical communications, and Kingboard groups, while gold stocks and new energy vehicles weakened.
- XPeng dropped nearly 8 % following its earnings report, while major technology stocks diverged amid company share-buyback activities.
- Hong Kong stocks declined significantly on August 24, with the Hang Seng Index falling 1.96% to 25498.35 points and the Hang Seng Tech Index dropping 3.67% to 4591.12 points.
- Alibaba plummeted over 9% after raising approximately 79.7 billion HKD through a massive share placement for AI infrastructure, dragging down internet and semiconductor stocks.
- Meanwhile, oil stocks, surging gold prices driven by safe-haven demand, and select new consumption shares bucked the broader market downward trend.
- On August 24, Hong Kong stocks declined significantly, with the Hang Seng Index falling 2.00% to 25488.47 points.
- Alibaba's record 80 billion HKD share placement triggered a sharp drop in tech stocks, while Michael Burry's clearance of his stake added to market concerns.
- Meanwhile, petroleum and gold stocks strengthened counter-trend due to strong corporate earnings and surging gold prices exceeding 4700 USD per ounce.
- On August 20 morning close, Hong Kong stocks rose collectively with the Hang Seng Index up 1.14% to 25786.32 points and a total turnover of about 1441 billion HKD.
- Propelled by Moderna's cancer vaccine breakthrough, the mRNA and innovative drug sectors surged strongly with Leading stocks like Everly Health soaring over 68% and CanSino jumping over 51%.
- Meanwhile, Kuaishou dropped nearly 10% following its earnings report and subsequent rating downgrades, while Xiaomi and Ideal Auto gained on positive financial results and vehicle-to-countryside policies.
- On August 20, Hong Kong stocks rallied collectively, with the Hang Seng Index rising 0.74% to 25684.92 points.
- Sector performance showed gold stocks surging driven by safe-haven demand, pharmaceutical stocks strengthening following positive overseas clinical trial results, and new energy vehicle stocks posting gains.
- Kuaishou shares plunged over 11% following its second-quarter financial results reporting a 36% year-on-year drop in net profit.